Vascular Surgery Laboratories
Research in the Division of Vascular Surgery has two primary foci:
- Basic Science investigations are ongoing to evaluate the pathophysiology of restenosis or intimal hyperplasia. These studies focus on signaling systems in vascular smooth muscle cells that lead to abnormal behavior of these cells. The vascular research laboratory is NIH funded; current projects include an evaluation of Transforming Growth Factor beta and its signaling proteins and their role in smooth muscle cell proliferation, migration, and matrix protein production. Similar studies are being performed with the signaling protein, Protein Kinase C. Fellows involved in the laboratory will gain experience with a wide variety of molecular and physiological techniques. Studies involve not only basic molecular biology, but also the evaluation of injury models in animals. During the past 10 years, over 15 fellows have trained in the laboratory and all have been productive
- The Division of Vascular Surgery has partnered with the Inchoir group of Columbia University to evaluate outcomes associated with vascular interventions. Techniques used in these studies include the evaluation of large data sets such as local and regional databases, decision analysis, and quality of life. The focus of these studies has been to evaluate the wide array of new technology that is now available for vascular intervention. This collaboration has been extremely productive with a number of recent publications that focus on screening and treatment of abdominal aortic aneurysms. Fellows participating in these studies will become prepared for a future career including prospective funded clinical research.
For a list of recent publications or for a list of current or past Fellows, please feel free to contact Dr. K. Craig Kent, Chief, Division of Vascular Surgery, New York Presbyterian Hospital.
Back to Top